Australia's most trusted
source of pharma news
Friday, 29 August 2025
Posted 26 August 2025 AM
Bayer Australia has entered into a strategic partnership with Arrotex which will take over sales, marketing and distribution for Bayer’s established portfolio of oral contraceptive brands in Australia.
The agreement, which covers Yaz and Yasmin, reflects a shared commitment to "protecting and growing" access to the products, which were both listed on the PBS on 1 March as part of the Federal Government's $573.3 million women’s health package.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.